Julio Núñez

Research interests

Publications

• Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2313917

• Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

  The Lancet · 2024 · https://doi.org/10.1016/s0140-6736(24)00469-0

• Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2306963

• Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus

  Journal of Clinical Medicine · 2022 · 10.3390/jcm12010145

• The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

  Journal of the American Medical Directors Association · 2020 · https://doi.org/10.1016/j.jamda.2020.05.045

• Genetic Etiology for Alcohol-Induced Cardiac Toxicity

  Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.03.462

• Estrategias para la elaboración de modelos estadísticos de regresión

  Revista Española de Cardiología · 2011 · 10.1016/j.recesp.2011.01.019

• Usefulness of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality in ST Segment Elevation Myocardial Infarction

  The American Journal of Cardiology · 2008 · https://doi.org/10.1016/j.amjcard.2007.11.004

Current projects

No projects listed.